Horizons in Cancer Research. Volume 54

Hiroto S. Watanabe (Editor)

Series: Horizons in Cancer Research
BISAC: MED062000

Clear

$230.00

Volume 10

Issue 1

Volume 2

Volume 3

Special issue: Resilience in breaking the cycle of children’s environmental health disparities
Edited by I Leslie Rubin, Robert J Geller, Abby Mutic, Benjamin A Gitterman, Nathan Mutic, Wayne Garfinkel, Claire D Coles, Kurt Martinuzzi, and Joav Merrick

eBook

Digitally watermarked, DRM-free.
Immediate eBook download after purchase.

Product price
Additional options total:
Order total:

Quantity:

Details

This book presents original results on the leading edge of cancer research. Topics discussed include the risk factors, diagnosis and treatment options for glioblastoma; the biology of the interleukin-2 (il-2)-based immunotherapies in cancer and autoimmune disease; RNA interference for cancer therapeutics; melanoma progression to metastatic disease; proteins, polysaccharide-peptide complexes and polysaccharides with antiproliferative and anticancer properties of mushroom origin; low-molecular-weight compounds with anticancer activity of mushroom origin; lifestyle and cancer prevention; and the pathology and pathogenesis of Hodgkin’s lymphoma. (Imprint: Nova Biomedical )

Preface

Chapter 1 - Glioblastoma: Risk Factors, Diagnosis and Treatment Options (pp. 1-30)
Kyung-Sub Moon and Maciej S. Lesniak (The Brain Tumor Center, The University of Chicago Medical Center, Chicago, IL, USA)

Chapter 2 - The Biology of the Interleukin-2 (IL-2)-Based Immunotherapies in Cancer and Autoimmune Disease (pp. 31-52)
André Ballesteros-Tato and Troy D. Randall (Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, USA)

Chapter 3 - OFF or ON: RNA Interference (RNAi) / RNA Activation (RNAa) for Cancer Therapeutics (pp. 53-66)
Sorah Yoon and John J. Rossi (Department of Molecular and Cellular Biology, Beckman Research, Institute of City of Hope, Duarte, California, USA)

Chapter 4 - Melanoma Progression to Metastatic Disease: The Role of the PI3K/AKT and Wnt/β-Catenin Pathways (pp. 67-104)
Jaskiran Sidhu, Geetha Venkateswaran and Sujata Persad (Department of Pediatrics Faculty of Medicine and Dentistry University of Alberta, Edmonton, Alberta, Canada)

Chapter 5 - Mushrooms: Proteins, Polysaccharide-Peptide Complexes and Polysaccharides with Antiproliferative and Anticancer Activities (pp. 105-120)
Tzi Bun Ng, Jack Ho Wong, Randy Chi Fai Cheung, Tak Fu Tse, Timothy Tam and Helen Chan (School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, China)

Chapter 6 - Low-Molecular-Weight Compounds with Anticancer Activity of Mushroom Origin (pp. 121-132)
Tzi Bun Ng and Charlene Cheuk Wing Ng (School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, China)

Chapter 7 - Lifestyle and Cancer Prevention (pp. 133-148)
Hirokazu Takahashi (Gastroenterology Division, Yokohama City University Graduate School of Medicine, Yokohama, Japan)

Chapter 8 - Pathology and Pathogenesis of Hodgkin‘s Lymphoma: Analysis of Its Status over a Period of Five Decades (pp. 149-184)
Dilip K. Das (Department of Pathology, Faculty of Medicine, Kuwait University, Kuwait)

Index

You have not viewed any product yet.